美国 · 平台与数据 · MarketBeat

Braveheart Bio Shares One-Year Heart Drug Data, Plans New Fixed-Dose Trial

来源：MarketBeat · 美国 35 分钟前

Braveheart Bio (NASDAQ:BRVE) presented one-year data from a small study of its experimental heart drug BHB-1893 and outlined plans for a fixed-dose trial, as the company advances…

在 MarketBeat 阅读全文登录后可收藏

MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.marketbeat.com)

Braveheart Bio Shares One-Year Heart Drug Data, Plans New Fixed-Dose Trial

推荐阅读

Franklin (BEN) Q4 2026 Earnings Call Transcript

Gogo reiterates $870M-$895M 2026 revenue guidance while outlining Galileo speeds to over 1 gigabit by 2032

Haiti PM says gang leader Mathias Saintil dead

‘I have no financial safety net’: I’m 66, rely on Social Security and have just $500 in savings. What hope do I have?

Nasdaq drops into correction territory — here’s what typically happens next

Strawberry Fields (STRW) Q3 2026 Earnings Call Transcript

Braveheart Bio Shares One-Year Heart Drug Data, Plans New Fixed-Dose Trial

分享

推荐阅读

Franklin (BEN) Q4 2026 Earnings Call Transcript

Gogo reiterates $870M-$895M 2026 revenue guidance while outlining Galileo speeds to over 1 gigabit by 2032

Haiti PM says gang leader Mathias Saintil dead

‘I have no financial safety net’: I’m 66, rely on Social Security and have just $500 in savings. What hope do I have?

Nasdaq drops into correction territory — here’s what typically happens next

Strawberry Fields (STRW) Q3 2026 Earnings Call Transcript